Teladoc Health, Inc. $TDOC Shares Acquired by Marathon Trading Investment Management LLC

Key Points

• Marathon Trading Investment Management LLC increased its stake in Teladoc Health by 350% in the first quarter, now owning 54,000 shares worth approximately $430,000.
• Teladoc Health reported a loss of ($0.19) EPS for the last quarter, surpassing analysts' expectations, with revenue of $631.90 million.
• The current consensus rating for Teladoc Health among analysts is "Hold," with a target price of $9.76.

Marathon Trading Investment Management LLC raised its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 350.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 54,000 shares of the health services provider's stock after acquiring an additional 42,000 shares during the period. Marathon Trading Investment Management LLC's holdings in Teladoc Health were worth $430,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in TDOC. Point72 Asset Management L.P. raised its position in Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock worth $101,625,000 after purchasing an additional 2,813,568 shares during the period. Maple Rock Capital Partners Inc. boosted its position in shares of Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after buying an additional 2,331,000 shares during the period. Two Sigma Investments LP bought a new position in shares of Teladoc Health during the fourth quarter valued at approximately $18,348,000. Two Sigma Advisers LP grew its stake in shares of Teladoc Health by 213.0% during the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock valued at $20,532,000 after buying an additional 1,537,094 shares during the last quarter. Finally, Nuveen LLC purchased a new stake in shares of Teladoc Health in the first quarter worth approximately $11,789,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Stock Down 1.7%

Shares of NYSE:TDOC traded down $0.1250 on Wednesday, reaching $7.2150. The company had a trading volume of 4,611,390 shares, compared to its average volume of 7,641,047. The firm has a market capitalization of $1.27 billion, a PE ratio of -6.06 and a beta of 1.76. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. Teladoc Health, Inc. has a 52-week low of $6.35 and a 52-week high of $15.21. The firm's 50 day simple moving average is $7.72 and its 200-day simple moving average is $8.26.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm had revenue of $631.90 million during the quarter, compared to analysts' expectations of $621.91 million. During the same period in the prior year, the business posted ($0.38) EPS. The firm's quarterly revenue was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

TDOC has been the subject of a number of recent analyst reports. Wells Fargo & Company dropped their price objective on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a report on Thursday, May 8th. Mizuho initiated coverage on Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 target price for the company. Bank of America lowered their target price on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research note on Wednesday, May 28th. Citigroup cut their price target on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a report on Friday, April 25th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Six equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Teladoc Health presently has a consensus rating of "Hold" and an average target price of $9.75.

Insider Activity

In other news, insider Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total value of $28,842.34. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Carlos Nueno sold 3,958 shares of the business's stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $27,151.88. Following the transaction, the insider owned 17,645 shares of the company's stock, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 18,656 shares of company stock worth $128,189. Corporate insiders own 0.58% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.